Skip to main content
SpringerLink
Log in

Defects in Host Defense Mechanisms

  • Chapter
Clinical Approach to Infection in the Compromised Host

Abstract

Under normal conditions, large areas of the human body surface are colonized with microorganisms. The skin and the mucous membranes of the oropharynx, nasopharynx, intestinal tract, and parts of the genital tract each have their own microflora.1 These patterns of colonization are determined by microbial factors, exogenous factors, and host factors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Mackowiak PA: The normal microbial flora. N Engl J Med 307: 83–93, 1982.

    Article  PubMed  CAS  Google Scholar 

  2. Abraham SN, Beachy EH: Host defenses against adhesion of bacteria to mucosal surfaces. In Gallin JI, Fauci AS (eds): Advances in Host Defense Mechanisms, Vol. 4. Raven Press, New York, 1985, pp. 63–88.

    Google Scholar 

  3. Savage DC: Colonization by and survival of pathogenic bacteria on intestinal mucosal surfaces. In Britton G, Marschall KC (eds): Adsorption of Microorganisms to Surfaces. John Wiley, New York, 1980, pp. 175–206.

    Google Scholar 

  4. Guiot HFL: Role of competition for substrate in bacterial antagonism in the gut. Infect Immun 38: 887–892, 1982.

    PubMed  CAS  Google Scholar 

  5. van den Waay D, Berghuis-de Vries JM, Lekkerkerk-van den Wees JEC: Colonization resistance of the digestive tract and the spread of bacteria to the lymphatic organs in mice. J Hyg (Cambridge) 70: 335–342, 1972.

    Article  Google Scholar 

  6. Heczko PB, Pryjma J, Kasprowicz J, et al: Influence of host and parasite factors on the nasal carriage of Staphylococci. In Jeljaszawicz J (ed): Staphylococci and Staphylococcal Infection. S. Karger, Basel, New York, 1973, pp. 581–594.

    Google Scholar 

  7. Young LS, LaForce FM, Head JJ, et al: A simultaneous outbreak of meningococcal and influenza infections. N Engl J Med 287: 5–9, 1972.

    Article  PubMed  CAS  Google Scholar 

  8. Sanford BA, Shelokov A, Ramsay MA: Bacterial adherence to virus infected cells: A culture model of bacterial superinfection. J Infect Dis 137: 176–181, 1978.

    Article  PubMed  CAS  Google Scholar 

  9. Kominis SD, Copeland CE, Grosiak B, et al: Introduction of Pseudomonas aeruginosa into a hospital via vegetables. Appl Microbiol 24: 567–570, 1972.

    Google Scholar 

  10. Pollack M, and Charache P, Nieman RE: Factors influencing colonisation and antibiotic-resistant pathogens of gram-negative bacteria in hospital patients. Lancet 2: 668–671, 1972.

    Article  PubMed  CAS  Google Scholar 

  11. Beachy EH: Bacterial adherence: Adhesion-receptor interactions mediating the attachment of bacteria to mucosal surfaces. J Infect Dis 143: 325–345, 1981.

    Article  Google Scholar 

  12. Johnson JR: Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4: 80–128, 1991.

    PubMed  CAS  Google Scholar 

  13. Kinsman OS, McKenna R, Noble WC: Association between histocompatibility antigens and nasal carriage of Staphylococcus aureus. J Med Microbiol 16: 215–220, 1983.

    Article  PubMed  CAS  Google Scholar 

  14. Noble WC: Carriage of Staphylococcus aureus and beta-hemolytic streptococci in relation to race. Acta Dermatol Venerol 54: 403–405, 1974.

    CAS  Google Scholar 

  15. Winkler J, Block C, Leibovici L, et al: Nasal carriage of Staphylococcus aureus: Correlation with hormonal status in women. J Infect Dis 162: 1400–1402, 1990.

    Article  PubMed  CAS  Google Scholar 

  16. Thadepalli H, Chan WH, Maidman JE, et al: Microflora of the cervix during labor and the puerperium. J Infect Dis 137: 568–572, 1978.

    Article  PubMed  CAS  Google Scholar 

  17. Mackowiak PA, Martin, RM, Smith JW: The role of bacterial interference in the increased prevalence of oropharyngeal gram negative bacilli among alcoholics and diabetics. Am Rev Respir Dis 120: 589–593, 1979.

    PubMed  CAS  Google Scholar 

  18. Tuazon CU, Sheagren JN: Increased staphylococcal carrier rate among narcotic addicts. J Infect Dis 129: 725–727, 1974.

    Article  PubMed  CAS  Google Scholar 

  19. Chow JW, Yu VL: Staphylococcal nasal carriage in hemodialysis patients. Arch Intern Med 149: 1258–1262, 1989.

    Article  PubMed  CAS  Google Scholar 

  20. Klein RS, Recco RA, Cataland MT, et al: Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med 297: 800–802, 1977.

    Article  PubMed  CAS  Google Scholar 

  21. Alpern RJ, Dowell VR, Jr.: Clostridium septicum: Infections and malignancy. JAMA 209: 385–388, 1969.

    Article  PubMed  CAS  Google Scholar 

  22. Black PH, Kunz LJ, Swartz MN: Salmonellosis—a review of some unusual aspects. N Engl J Med 262: 811–817, 864-870, 921-927, 1960.

    Article  PubMed  CAS  Google Scholar 

  23. Reichert U, Saint Leger D, Schaeffer H: Skin surface chemistry and microbial infection. Semin Dermatol 1: 91–100, 1982.

    Google Scholar 

  24. Smith RF: Lactic acid utilization by the cutaneous Micrococcaceae. Microbiologia 21: 777–779, 1971.

    CAS  Google Scholar 

  25. Blank I, Oawes RK: The water content of Stratum corneum: The importance of water in promoting bacterial multiplication on cornified epithelium. J Invest Dermatol 31: 141–145, 1958.

    PubMed  CAS  Google Scholar 

  26. Newhouse M, Sanchis J, Bienenstock J: Lung defense mechanisms. N Engl J Med 295: 990–998, 1310-1320, 1976.

    Article  PubMed  CAS  Google Scholar 

  27. Giannella RA, Broitman SA, Zamcheck N: Influence of gastric acidity on bacterial and parasite enteric infections. Ann Intern Med 78: 271–276. 1973.

    PubMed  CAS  Google Scholar 

  28. Binder HJ, Filburn B, Floch M: Bile acid inhibition of intestinal anaerobic organisms. Am J Clin Nutr 28: 119–125, 1974.

    Google Scholar 

  29. Hinman F Jr., Cox CE: The voiding vesical defense mechanism: The mathematical effect of residual urine, voiding interval and volume on bacteriuria. J Urol 96: 491–498, 1966.

    PubMed  Google Scholar 

  30. Klebanoff SJ, Hillier SL, Eschenback DA, et al: Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis 164: 94–100, 1991.

    Article  PubMed  CAS  Google Scholar 

  31. Strominger JL, Tipper DJ: Structure of bacterial cell walls: The lysozyme substrate. In Osserman E, Canfield W (eds): Lysozyme. Academic Press, New York, 1974, pp. 169–184.

    Google Scholar 

  32. Masson PL, Heremans JF, Schonne E: Lactoferrin, an iron binding protein in neutrophilic leukocytes. J Exp Med 130: 643–658, 1969.

    Article  PubMed  CAS  Google Scholar 

  33. McClelland DBL, van Furth R: In vitro synthesis of lysozyme by human and mouse tissues and leucocytes. Immunology 28: 1099–1114, 1975.

    PubMed  CAS  Google Scholar 

  34. Joiner KA, Brown EJ, Frank MM: Complement and bacteria: Chemistry and biology in host defense. Annu Rev Immunol 2: 461–491, 1984.

    Article  PubMed  CAS  Google Scholar 

  35. Figueroa JE, Densen P: Infectious diseases associated with complement deficiencies. Clin Microb Rev 4: 359–395, 1991.

    CAS  Google Scholar 

  36. Daha MR: Biological properties of immune complexes. Neth J Med 27: 375–379, 1984.

    PubMed  CAS  Google Scholar 

  37. Alper CA, Colten HR, Gear JSS, et al: Homozygous human C3 deficiency. J Clin Invest 57: 222–229, 1976.

    Article  PubMed  CAS  Google Scholar 

  38. Roord JJ, Daha MR, Kuis W, et al: Inherited deficiency of the third component of complement associated with recurrent pyogenic infections, circulating immune complexes and vasculitis in a Dutch family. Pediatrics 71: 81–89, 1983.

    PubMed  CAS  Google Scholar 

  39. Snyderman R, Durack DT, McCarthey GA: Deficiency of the fifth component of complement in human subjects. Am J Med 67: 638–645, 1979.

    Article  PubMed  CAS  Google Scholar 

  40. Miller ME, Koblenzer PT: Leiner’s disease and deficiency of C5. J Pediatr 80: 879–880, 1972.

    Article  PubMed  CAS  Google Scholar 

  41. Ellison RT, Kohler PF, Curd JG: Prevalence of congenital or acquired complement deficiency in patients with sporadic meningococcal disease. N Engl J Med 308: 913–916, 1983.

    Article  PubMed  Google Scholar 

  42. Newman SL, Vogler LB, Feigin RD, et al: Recurrent septicemia associated with congenital deficiency of C2 and partial deficiency of factor B of the alternative complement pathway. N Engl J Med 299: 290–292, 1978.

    Article  PubMed  CAS  Google Scholar 

  43. Kluin-Nelemans H, van Velzen-Blad H, van Helden HPT, et al: Functional deficiency of complement factor D in a monozygous twin. Clin Exp Immunol 58: 724–730, 1984.

    PubMed  CAS  Google Scholar 

  44. Ziegler JB, Alper CA, Rosen FS, et al: Restoration by purified C3b inactivator of complement-mediated functions in vivo in a patient with C3b inactivator deficiency. J Clin Invest 55: 668–672, 1975.

    Article  PubMed  CAS  Google Scholar 

  45. Johnston RB Jr, Newman LS, Struth AG: An abnormality of the alternate pathway of complement activation in sickle cell disease. N Engl J Med 288: 803–808, 1973.

    Article  PubMed  Google Scholar 

  46. Hand WL, King NL: Serum opsonization of Salmonella in sickle cell anemia. Am J Med 64: 388–395, 1978.

    Article  PubMed  CAS  Google Scholar 

  47. Fearon DT, Ruddy S, Schur PH, et al: Activation of the properdin pathway of complement in patients with gram negative bacteremia. N Engl J Med 292: 937–940, 1975.

    Article  PubMed  CAS  Google Scholar 

  48. Rytel MW, Dee TH, Ferstenfeld JE, et al: Possible pathogenic role of capsular antigens in fulminant pneumococcal disease with disseminated intravascular coagulation. Am J Med 57: 889–896, 1974.

    Article  PubMed  CAS  Google Scholar 

  49. Greenwood BM, Brueton MJ: Complement activation and meningococcal infection. Br Med J 1: 797–799, 1976.

    Article  PubMed  CAS  Google Scholar 

  50. Dance DAB, Smith CL: Complement deficiency and sporadic meningococcal disease. N Engl J Med 309: 615, 1983.

    Article  Google Scholar 

  51. Lehman TJH, Bernstein B, Hanson V, et al: Meningococcal infection complicating systemic lupus erythematosus. J Pediatr 99: 94–96, 1981.

    Article  PubMed  CAS  Google Scholar 

  52. Breedveld FC, van den Barselaar MT, Leijh PCJ, et al: Phagocytosis and intracellular killing by polymorphonuclear cells from patients with rheumatoid arthritis and Felty’s syndrome. Arthritis Rheum 28: 166–173, 1985.

    Article  Google Scholar 

  53. Hostetter MK: Effects of hyperglycemia on C3 and Candida albicans. Diabetes 39: 271–275, 1990.

    Article  PubMed  CAS  Google Scholar 

  54. Lachmann PJ: Antibody and complement in viral infections. Br Med Bull 41: 3–6, 1985.

    PubMed  CAS  Google Scholar 

  55. Proctor RA: Fibronectin: A brief overview of its structure, function, and physiology. Rev Infect Dis 9: S317–321, 1987.

    Article  PubMed  CAS  Google Scholar 

  56. Tamkun JW, Hynes RO: Plasma fibronectin is synthesized and secreted by hepatocytes. J Biol Chem 258: 4641–4647, 1983.

    PubMed  CAS  Google Scholar 

  57. Bevilacqua M, Amrani D, Mosesson MW, et al: Receptors for cold-insoluble globulin (plasma fibronectin) on human monocytes. J Exp Med 153: 42–60, 1981.

    Article  PubMed  CAS  Google Scholar 

  58. Proctor RA: Fibronectin: An enhancer of phagocyte function. Rev Infect Dis 9: S412–417, 1987.

    Article  PubMed  CAS  Google Scholar 

  59. Mosher DF, Williams EM: Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. J Lab Clin Med 91: 729–735, 1978.

    PubMed  CAS  Google Scholar 

  60. Grossmann JE: Plasma fibronectin and fibronectin therapy in sepsis and critical illness. Rev Infect Dis 9: S420–430, 1987.

    Article  Google Scholar 

  61. Shirakami A, Shigekiyo T, Hirai Y: Plasma fibronectin deficiency in eight members of one family. Lancet 1: 473–475, 1986.

    Article  PubMed  CAS  Google Scholar 

  62. Balkwill FR: Interferons. Lancet 1: 1060–1063, 1989.

    Article  PubMed  CAS  Google Scholar 

  63. Joklik WK: The molecular basis of the antiviral activity of interferons. Ann NY Acad Sci 350: 432–440, 1980.

    Article  PubMed  CAS  Google Scholar 

  64. Schellekens H, Weimar W, Cantell K, et al: Antiviral effect of interferon in vivo may be mediated by the host. Nature (London) 278: 742, 1979.

    Article  CAS  Google Scholar 

  65. Murray HW: Interferon-gamma: The activated macrophage and the host defense against microbial challenge. Ann Int Med 108: 595–608, 1988.

    PubMed  CAS  Google Scholar 

  66. Arenzana-Seisdedos F, Virelizier JL, Fiers W: Interferons as macrophage activating factors. EG. Preferential effects of interferon-alpha on the interleukin-1secretory potential of fresh or aged monocytes. J Immunol 134: 2444–2448, 1985.

    PubMed  CAS  Google Scholar 

  67. Ennis FA, Beare AS, Riley D, et al: Interferon induction and increased natural killer cell activity in influenza infections in man. Lancet 2: 891–893, 1981.

    Article  PubMed  CAS  Google Scholar 

  68. Bryson YJ, Winter HS, Gard SE, et al: Deficiency of immune interferon production by leukocytes of normal newborns. Cell Immunol 55: 191–200, 1980.

    Article  PubMed  CAS  Google Scholar 

  69. Epstein LB, Ammon AJ: Evaluation of T lymphocyte effector function in immunodeficiency diseases: Abnormality in mitogenstimulated interferon in patients with selective IgA deficiency. J Immunol 112: 617–626, 1974.

    PubMed  CAS  Google Scholar 

  70. Lipinski M, Virelizier JL, Tursz T, et al: Natural killer cell activities in patients with primary immunodeficiencies or defects in immune interferon production. Eur J Immunol 10: 246–249, 1980.

    Article  PubMed  CAS  Google Scholar 

  71. Virelizier JL, Lenoir G, Griscelli C: Persistent Epstein-Barr virus infection in a child with hypogammaglobulinemia and immu noblastic proliferation associated with selective defect in immune interferon secretion. Lancet 2: 231–234, 1978.

    Article  PubMed  CAS  Google Scholar 

  72. Murray HW, Rubin BY, Masur H, et al: Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med 310: 883–889, 1984.

    Article  PubMed  CAS  Google Scholar 

  73. Buimovici-Klein E, Lange M, Ramey WG, et al: Cell-mediated immune responses in AIDS. N Engl J Med 311: 328–329, 1984.

    Article  PubMed  CAS  Google Scholar 

  74. Rossol S, Voth R, Laubenstein HP, et al: Interferon production in patients infected with HIV-1. J Infect Dis 159: 815–820, 1989.

    Article  PubMed  CAS  Google Scholar 

  75. Rytel MW, Balay J: Impaired production of interferon in lymphocytes from immunosuppressed patients. J Infect Dis 127: 445–449, 1973.

    Article  PubMed  CAS  Google Scholar 

  76. Weimar W, van Ruyven CM, Geerlings W, et al: Gamma interferon production capacity after renal transplantation. Transplant Proc 15: 421–423, 1983.

    Google Scholar 

  77. Rhodes-Feuillette A, Canivet M, Devergie A, et al: Circulating interferon after marrow transplant in cytomegalovirus infection. Lancet 1: 1217, 1981.

    Article  PubMed  CAS  Google Scholar 

  78. Aarden LA, Brunner TK, Cerotini JC, et al: Revised nomenclature for antigen-non-specific T cell proliferation and helper factors [letter]. J Immunol 123: 2928–2929, 1979.

    CAS  Google Scholar 

  79. Dinarello CA: Interleukin-1. FASEB J 2: 108–115, 1988.

    PubMed  CAS  Google Scholar 

  80. Beutler B, Cerami A: Cachectin: More than a tumor necrosis factor. N Engl J Med 316: 379–385, 1987.

    Article  PubMed  CAS  Google Scholar 

  81. Van der Meer JWM, Barza M, Wolff SM, et al: Low dose recombinant interleukin-1 protects granulocytopenic mice from lethal gram-negative infection. Proc Natl Acad Sci USA 85: 1620–1623, 1988.

    Article  PubMed  Google Scholar 

  82. Kindler V, Sappino AP, Grau GE, et al: The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56: 731–740, 1989.

    Article  PubMed  CAS  Google Scholar 

  83. Waage A, Brandtzaeg P, Halstensen A, et al: The complex pattern of cytokines in serum from patients with meningococcal septic shock: Association between interleukin-6, interleukin-1, and fatal outcome. J Exp Med 169: 333–338, 1989.

    Article  PubMed  CAS  Google Scholar 

  84. Cannon JG, Tompkins RG, Gelfand JA, et al: Circulating interleukin-1 in septic shock and experimental endotoxin fever. J Infect Dis 161: 79–84, 1990.

    Article  PubMed  CAS  Google Scholar 

  85. Okusawa S, Gelfand JA, Ikejima T, et al: Interleukin-1 induces a shock-like state in rabbits: Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 81: 1162–1172, 1988.

    Article  PubMed  CAS  Google Scholar 

  86. Grau GE, Taylor TE, Molyneux ME, et al: Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 320: 1586–1591, 1989.

    Article  PubMed  CAS  Google Scholar 

  87. Mier JW, Vachino G, Van der Meer JWM, et al: Induction of circulating tumor necrosis factor (TNF-gamma) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients. J Clin Immunol 8: 426–436, 1988.

    Article  PubMed  CAS  Google Scholar 

  88. Kuziel WA, Greene WC: Interleukin-2. In Thomson A (ed): The Cytokine Handbook. Academic Press, London, San Diego, 1991, pp. 83–102.

    Google Scholar 

  89. Rosenberg SA, Lotze MT, Muul LM, et al: A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-1 or high-dose interleukin-2 alone. N Engl J Med 316: 889–897, 1987.

    Article  PubMed  CAS  Google Scholar 

  90. Schrader JW: Interleukin-3. In Thomson A (ed): The Cytokine Handbook. Academic Press, London, San Diego, 1991, pp. 103–118.

    Google Scholar 

  91. Banchereau J: Interleukin-4. In Thomson A (ed): The Cytokine Handbook. Academic Press, London, San Diego, 1991, pp. 119–148.

    Google Scholar 

  92. Carter KC, Gallagher G, Baillie AJ, et al: The induction of protective immunity to Leishmania major in the BALB/c mouse by interleukin-4 treatment. Eur J Immunol 19: 779–782, 1989.

    Article  PubMed  CAS  Google Scholar 

  93. Sanderson CJ: Interleukin-5. In Thomson A (ed): The Cytokine Handbook. Academic Press, London, San Diego, 1991, pp. 149–167.

    Google Scholar 

  94. Van Snick J: Interleukin-6: An overview. Annu Rev Immunol 8: 253–278, 1990.

    Article  PubMed  Google Scholar 

  95. Gauldie J, Richards C, Harnish D, et al: Interferon beta-2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84: 7251–7255, 1987.

    Article  PubMed  CAS  Google Scholar 

  96. Schindler R, Mancilla J, Endres S, et al: Correlations and interactions in the production of interleukin-6 (IL-6), interleukin-1 (IL-1), and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75: 40–47, 1990.

    PubMed  CAS  Google Scholar 

  97. Goodwin RG, Namen AE: Interleukin-7. In Thomson A (ed): The Cytokine Handbook. Academic Press, London, San Diego, 1991, pp. 192–200.

    Google Scholar 

  98. Van Damme J: Interleukin-8. In Thomson A (ed): The Cytokine Handbook. Academic Press, London, San Diego, 1991, pp. 201–214.

    Google Scholar 

  99. Renauld JC, Goethals A, Houssiau F, et al: Human P40/interleukin-9: Expression in activated CD4+ T cells, genomic organization, and comparison with the mouse gene. J Immunol 144: 4235–4241, 1990.

    PubMed  CAS  Google Scholar 

  100. Donahue RE, Yang YC, Clark SC: Human P40 T cell growth factor (interleukin-9) supports erythroid colony formation. Blood 75: 2271–2275, 1990.

    PubMed  CAS  Google Scholar 

  101. Williams DE, Morrissey PJ, Mochizuki DY, et al: T-cell growth factor P40 promotes the proliferation of myeloid cell lines and enhances erythroid burst formation by normal murine bone marrow cells in vitro. Blood 76: 906–911, 1990.

    PubMed  CAS  Google Scholar 

  102. Zlotnik A, Moore KW: Interleukin-10. Cytokine 3: 336–371, 1991.

    Article  Google Scholar 

  103. Groopman JE, Molina JM, Scadden DT: Hematopoietic growth factors, biology, and clinical applications. N Engl J Med 321: 1449–1459, 1989.

    Article  PubMed  CAS  Google Scholar 

  104. Moore MA: The clinical use of colony stimulating factors. Annu Rev Immunol 9: 159–191, 1991.

    Article  PubMed  CAS  Google Scholar 

  105. Baldwin GC, Gasson JC, Quan SG: Granulocyte-macrophage colony stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients. Proc Natl Acad Sci USA 85: 2763–2766, 1988.

    Article  PubMed  CAS  Google Scholar 

  106. Roilides E, Walsh TJ, Pizzo PA, et al: Granulocyte colony stimulating factor enhances the phagocytic and bactericidal activity of normal and defective neutrophils. J Infect Dis 163: 579–583, 1991.

    Article  PubMed  CAS  Google Scholar 

  107. Nathan CF: Respiratory burst in adherent human neutrophils: triggering by colony stimulating factors CSF-GM and CSF-G. Blood 73: 301–306, 1989.

    PubMed  CAS  Google Scholar 

  108. Ikejima T, Okusawa S, Ghezzi P, et al: Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. J Infect Dis 162: 215–223, 1990.

    Article  PubMed  CAS  Google Scholar 

  109. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 77: 1627–1652, 1991.

    PubMed  CAS  Google Scholar 

  110. Engelmann H, Novick D, Wallach D: Two tumor necrosis factorbinding proteins purified from human urine: Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem 265: 1531–1536, 1990.

    PubMed  CAS  Google Scholar 

  111. Chantry D, Turner M, Abney E, et al: Modulation of cytokine production by transforming growth factor-beta. J Immunol 142: 4295–4300, 1989.

    PubMed  CAS  Google Scholar 

  112. Tonegawa S: Somatic generation of antibody diversity. Nature (London) 302: 575–581, 1983.

    Article  CAS  Google Scholar 

  113. Oxelius VA: Chronic infections in a family with hereditary deficiency of IgG2 and IgG4. Clin Exp Immunol 17: 19–27, 1974.

    PubMed  CAS  Google Scholar 

  114. Siber GR, Schur PH, Aisenberg AC, et al: Correlation between serum IgG2-concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med 303: 178–182, 1980.

    Article  PubMed  CAS  Google Scholar 

  115. Tomasi TB, Plaut AG: Humoral aspects of mucosal immunity. In Gallin JI, Fauci AS (eds): Advances in Host Defense Mechanisms, Vol. 4. Raven Press, New York, 1985, pp. 31–61.

    Google Scholar 

  116. Andre C, Andre F, Fargier MC: Distribution of IgAl and IgA2 plasma cells in various normal human tissues and in the jejunum of plasma IgA deficient patients. Clin Exp Immunol 33: 327–331, 1978.

    PubMed  CAS  Google Scholar 

  117. Buckley RH, Becker WG: Abnormalities in the regulation of human IgE synthesis. Immunol Rev 41: 288–314, 1978.

    Article  PubMed  CAS  Google Scholar 

  118. Dessaint JP, Capron A, Joseph M: Interaction of schistosomiasis and macrophages. In van Furth R (ed): Mononuclear Phagocytes: Characteristics, Physiology, and function. Marinus Nijhoff Publishers, Boston, Dordrecht, Lancaster, 1985, pp. 593–598.

    Google Scholar 

  119. Vadas MA, Butterworth AE, Colley DG, et al: Interactions between human eosinophils and schistosomula of Schistosoma mansoni. I. Stable and irreversible antibody-dependent adherence. J Immunol 124: 1441–1448, 1980.

    PubMed  CAS  Google Scholar 

  120. Thorbecke GJ, Leski GA: Immunoglobulin D: Structure and function. Ann NY Acad Sci 399: 1–410, 1982.

    Article  Google Scholar 

  121. Rosen FS, Cooper MD, Wedgwood RJP: The primary immunodeficiencies. N Engl J Med 311: 235–242, 300-310, 1984.

    Article  PubMed  CAS  Google Scholar 

  122. Melamed I, Bujanover U, Igra VS, et al: Campylobacter enteritis in normal and immunodeficient children. Am J Dis Child 137: 752–753, 1983.

    PubMed  CAS  Google Scholar 

  123. Van der Meer JWM, Mouton RP, Daha MR, et al: Campylobacter jejuni bacteraemia as a cause of recurrent fever in a patient with hypogammaglobulinemia. J Infect Dis 12: 235–239, 1986.

    Google Scholar 

  124. Ochs HD, Ament ME, Davis SD: Giardiasis with malabsorption in X-linked agammaglobulinemia. N Engl J Med 287: 341–342, 1972.

    Article  PubMed  CAS  Google Scholar 

  125. Saulsbury FT, Bernstein MT, Winkelstein JA: Pneumocystis carinii pneumonia as the presenting infection in congenital hypogammaglobulinemia. J Pediatr 95: 559–561, 1979.

    Article  PubMed  CAS  Google Scholar 

  126. Wright PF, Hatch MH, Kasselberg AG, et al: Vaccine associated poliomyelitis in a child with sex-linked agammaglobulinemia. J Pediatr 91: 408–412, 1977.

    Article  PubMed  CAS  Google Scholar 

  127. McKinney RE, Katz SL, Wilfert CM: Chronic enteroviral meninoencephalitis in agammaglobulinemic patients. Rev Infect Dis 9: 334–356, 1987.

    Article  PubMed  Google Scholar 

  128. Saulsbury FT, Winkelstein, JA, Yolken RH: Chronic rotavirus infection in immunodeficiency. J Pediatr 97: 61–65, 1980.

    Article  PubMed  CAS  Google Scholar 

  129. So AK, Furr PM, Taylor-Robinson D, et al: Arthritis caused by Mycoplasma salivarium in hypogammaglobulinaemia. Br Med J 286: 762–763, 1983.

    Article  CAS  Google Scholar 

  130. Taylor-Robinson D, Furr PM, Webster AD: Ureaplasma urealyticum in the immunocompromised host. Pediatr Infect Dis 5: 236–238, 1986.

    Article  Google Scholar 

  131. Amman AJ, Hong R: Selective IgA deficiency: Presentation of 30 cases and a review of the literature. Medicine (Baltimore) 50: 223–236, 1971.

    Article  Google Scholar 

  132. Oxelius VA, Laurell AB, Lindquist B, et al: IgG subclasses in selective IgA deficiency: Importance of IgG2-IgG4 deficiency. N Engl J Med 304: 1476–1477, 1981.

    Article  PubMed  CAS  Google Scholar 

  133. Hobbs JR, Milner RDG, Watt PJ: Gamma-M deficiency predisposing to meningococcal septicaemia. Br Med J 4: 583–586, 1967.

    Article  PubMed  CAS  Google Scholar 

  134. Lefranc MP, Lefranc G, de Lange G, et al: Instability of the human immunoglobulin heavy chain constant region locus indicated by different inherited chromosomal deletions. Mol Biol Med 1: 207–217, 1983.

    PubMed  CAS  Google Scholar 

  135. Reinherz EL, Geha R, Wohl ME, et al: Immunodeficiency associated with loss of T4 + inducer T cell function. N Engl J Med 304: 811–816, 1981.

    Article  PubMed  CAS  Google Scholar 

  136. Eibl MM, Mannhalter JW, Zlabinger G, et al: Defective macrophage function in a patient with common variable immunodeficiency. N Engl J Med 307: 803–806, 1982.

    Article  PubMed  CAS  Google Scholar 

  137. Najjar VA, Fridkin M (eds): Antineoplastic, immunogenic and other effects of the tetrapeptide tuftsin: A natural macrophage activator. Ann NY Acad Sci 419: 1–273, 1983.

    Article  PubMed  CAS  Google Scholar 

  138. Corazza CR, Zoli G, Ginaldi L, et al: Tuftsin deficiency in AIDS. Lancet 337: 12–13, 1991.

    Article  PubMed  CAS  Google Scholar 

  139. Cronkite EP, Fliedner TM: Granulocytopoiesis. N Engl J Med 270: 1347–1352, 1964.

    Article  PubMed  CAS  Google Scholar 

  140. Joyce RA, Boggs DR, Hasiba U, et al: Marginal neutrophil pool size in normal subjects and neutropenic patients as measured by epinephrine infusion. J Lab Clin Med 88: 614–620, 1976.

    PubMed  CAS  Google Scholar 

  141. Gallin JI (moderator): Disorders of phagocyte chemotaxis. Ann Intern Med 92: 520–538, 1980.

    PubMed  CAS  Google Scholar 

  142. Springer TA, Dustin ML, Kishimoto TK, et al: The lymphocyte function-associated LFA-1, CD-2 and LFA-3 molecules: Cell adhesion receptors of the immune system. Annu Rev Immunol 5: 223–252, 1987.

    Article  PubMed  CAS  Google Scholar 

  143. Arnaout MA, Hakim RM, Todd III RF, et al: Increased expression of an adhesion promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med 312: 457–462, 1985.

    Article  PubMed  CAS  Google Scholar 

  144. Hogg N: The leukocyte integrins. Immunol Today 10: 24–32, 1989.

    Article  Google Scholar 

  145. Bass DA: Eosinophil behaviour during host defense reactions. In Gallin JI, Fauci AS (eds): Advances in Host Defense Mechanisms, Vol 1 New York, Raven Press, 1982, pp. 211–241.

    Google Scholar 

  146. Weller PF: The immunobiology of eosinophils. N Engl J Med 324: 1110–1114, 1991.

    Article  PubMed  CAS  Google Scholar 

  147. van Furth R, Diesselhoff-den Dulk MMC, Sluiter W, et al: New perspectives on the kinetics of mononuclear phagocytes. In van Furth R (ed): Mononuclear Phagocytes: Characteristics, Physiology, and function. Martinus Nijhoff Publishers, Boston, Dordrecht, Lancaster, 1985, pp. 201–208.

    Google Scholar 

  148. Goud TJ, Schotte C, van Furth R: Identification and characterization of the monoblast in mononuclear phagocyte colonies grown in vitro. J Exp Med 142: 1180–1199, 1975.

    Article  PubMed  CAS  Google Scholar 

  149. Van der Meer JWM, van de Gevel JS, Beelen RHJ, et al: Culture of human bone marrow in the Teflon culture bag: Identification of the human monoblast. J Reticuloendothel Soc 32: 355–369, 1982.

    PubMed  Google Scholar 

  150. van Furth R, Raeburn JR, van Zwet TL: Characteristics of human mononuclear phagocytes. Blood 54: 485–500, 1979.

    PubMed  Google Scholar 

  151. van Furth R: Cells of the mononuclear phagocyte system: Nomenclature in terms of sites and conditions. In van Furth R (ed): Mononuclear Phagocytes: Functional Aspects. Martinus Nijhoff Publishers, The Hague, Boston, London, 1980, pp. 1–30.

    Google Scholar 

  152. Burger EH, van der Meer JWM, van de Gevel JS, et al: In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes. J Exp Med 156: 1604–1614, 1982.

    Article  PubMed  CAS  Google Scholar 

  153. Snyderman R, Goetzl EJ: Molecular and cellular mechanisms of leucocyte chemotaxis. Science 213: 830–837, 1981.

    Article  PubMed  CAS  Google Scholar 

  154. Sluiter W, van Waarde D, Hulsing-Hesselink E, et al: Humoral control of monocyte production during inflammation. In van Furth R (ed): Mononuclear Phagocytes: Functional Aspects. Martinus Nijhoff Publishers, The Hague, Boston, London, 1980, pp. 325–339.

    Google Scholar 

  155. Griffin FM, Griffin JA, Leider JE, et al: Studies on the mechanisms of phagocytosis. I. Requirement for circumferential attachment of particle bound to specific receptors on the macrophage plasma membrane. J Exp Med 142: 1263–1282, 1975.

    Article  PubMed  Google Scholar 

  156. Leijh PCJ, van den Barselaar MT, van Furth R: Kinetics of phagocytosis and intracellular killing of Staphylococcus aureus and Escherichia coli by human monocytes. Scand J Immunol 13: 159–174, 1981.

    Article  PubMed  CAS  Google Scholar 

  157. Clark RA: The human neutrophil burst oxidase. J Infect Dis 161: 1140–1147, 1990.

    Article  PubMed  CAS  Google Scholar 

  158. Wright DG: The neutrophil as a secretous organ of host defense. In Gallin JI, Fauci AS (eds): Advances in Host Defense Mechanisms, Vol. 1. Raven Press, New York, 1982, pp. 75–110.

    Google Scholar 

  159. Lehrer RI, Ganz T: Antimicrobial peptides of human neutrophils. Blood 76: 2169-2181.

    Google Scholar 

  160. Moncada S, Higgs EA: Endogenous nitric oxide: Physiology, pathology and clinical relevance. Eur J Clin Invest 21: 361–374, 1991.

    Article  PubMed  CAS  Google Scholar 

  161. Arend WP, Mannik M: Studies on antigens-antibody complexes II: Quantitation of tissue uptake of soluble complexes in normal and complement depleted rabbits. J Immunol 107: 63–75, 1971.

    PubMed  CAS  Google Scholar 

  162. van Es LA, Daha MR, Kijlstra A: Clearance of soluble immune complexes and aggregates. In Peeters H (ed): Protides of the Biological Fluids. Pergamon Press, Oxford, New York, 1979, pp. 159–162.

    Google Scholar 

  163. Haakenstadt AO, Mannik M: Saturation of the reticuloendothelial system with soluble immune complexes. J Immunol 112: 1939–1948, 1974.

    Google Scholar 

  164. Atkinson JP, Frank MM: Studies on the in vivo effects of antibody: Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man. J Clin Invest 54: 339–348, 1974.

    Article  PubMed  CAS  Google Scholar 

  165. Nathan CF: Secretory products of macrophages. J Clin Invest 79: 319–326, 1987.

    Article  PubMed  CAS  Google Scholar 

  166. Unanue ER: Antigen presenting function of the macrophage. Annu Rev Immunol 2: 395–428, 1984.

    Article  PubMed  CAS  Google Scholar 

  167. Unanue ER, Allen PM: The basis for the immunoregulatory role of macrophages and other accessory cells. Science 236: 551–557, 1987.

    Article  PubMed  CAS  Google Scholar 

  168. Bodey GP, Buckley M, Sathe YS, et al: Quantitative relationships between circulating leucocytes and infection in patients with acute leukemia. Ann Intern Med 64: 328–340, 1966.

    PubMed  CAS  Google Scholar 

  169. Van der Meer JWM, Alleman M, Boekhout M: Infectious episodes in severely granulocytic patients. Infection 7: 171–175, 1979.

    Article  PubMed  Google Scholar 

  170. Dale DC, Dupont G, Wewerka JR, et al: Chronic neutropenia. Medicine (Baltimore) 58: 128–144, 1979.

    CAS  Google Scholar 

  171. Miles AA, Miles EM, Burke J: The value and duration of defense reactions of the skin to the primary lodgment of bacteria. Br J Exp Pathol 38: 79–96, 1957.

    PubMed  CAS  Google Scholar 

  172. Frank MM, Hamburger MI, Lawley TJ, et al: Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 300: 518–523, 1979.

    Article  PubMed  CAS  Google Scholar 

  173. Lobatto S, Daha MR, Breedveld FC, et al: Abnormal clearance of soluble aggregates of human immunoglobulin G in patients with systemic lupus erythematosus. Clin Exp Immunol 72: 55–59, 1988.

    PubMed  CAS  Google Scholar 

  174. Hamburger MI, Moutsopoulos HM, Lawley TJ, et al: Sjögren syndrome: A defect in reticuloendothelial system Fc receptor specific clearance. Ann Intern Med 91: 543–548, 1979.

    Google Scholar 

  175. Hamburger MI, Gerardi EH, Fields TR, et al: Lympho-plasmapheresis and reticuloendothelial system Fc receptor function in rheumatoid arthritis. Arthritis Rheum 24: S399: 4, 1981.

    Google Scholar 

  176. Kimberly RP, Imman RD, Bussel JB, et al: Modulation of mono-nuclear phagocyte system function and circulating immune complexes by lyophilized concentrates in patients with classic hemophilia. Clin Immunol Immunopathol 31: 321–330, 1984.

    Article  PubMed  CAS  Google Scholar 

  177. Ruiz P, Gomez F, Schreiber AD: Impaired function of macrophage Fcγ receptors in end-stage renal disease. N Eng J J Med 322: 717–722, 1990.

    Article  CAS  Google Scholar 

  178. Bender BS, Frank MM, Lawley TJ, et al: Defective reticuloendothelial system Fc-receptor function in patients with the acquired immunodeficiency syndrome. J Infect Dis 152: 409–412, 1985.

    Article  PubMed  CAS  Google Scholar 

  179. Lawley TJ, Hall RP, Fauci AS, et al: Defective Fc receptor functions associated with the HLA B8 DRW3 haplotype. N Engl J Med 304: 185–192, 1981.

    Article  PubMed  CAS  Google Scholar 

  180. Kimberly RP, Gibofsky J, Salmon JE, et al: Impaired Fc receptor mediated mononuclear phagocyte system clearance in HLA DR2 and MT1 positive healthy young adults. J Exp Med 157: 1698–1703, 1983.

    Article  PubMed  CAS  Google Scholar 

  181. Jaffe CJ, Vierling JM, Jones EA, et al: Receptor specific clearance by the reticuloendothelial system in chronic liver diseases: Demonstration of defective C3b-specific clearance in primary biliary cirrhosis. J Clin Invest 62: 1069–1077, 1978.

    Article  PubMed  CAS  Google Scholar 

  182. Biozzi G, Benacerraf B, Halpern BN, et al: Exploration of the phagocyte function of the reticuloendothelial system with heat denatured human serum albumin labeled with I-31 and applications to the measurement of liver blood flow in normal man and in some pathological conditions. J Lab Clin Med 51: 230–238, 1958.

    PubMed  CAS  Google Scholar 

  183. Lahnborg G, Friman L, Berghem L: Reticuloendothelial function in patients with alcoholic liver cirrhosis. Scand J Gastroenterol 16: 481–489, 1981.

    Article  PubMed  CAS  Google Scholar 

  184. Rimola A, Soto R: Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infection and prognosis. Hepatoloty 4: 53–58, 1984.

    Article  CAS  Google Scholar 

  185. Seidner DL, Mascioli EA, Istfan NW, et al: Effects of long-chain triglyceride emulsions of reticuloendothelial system function in humans. J Parent Ent Nutr 13: 614–619, 1989.

    Article  CAS  Google Scholar 

  186. Dwyer JM: Manipulating the immune system with immune globulin. N Engl J Med 326: 107–116, 1992.

    Article  PubMed  CAS  Google Scholar 

  187. Halma C, Daha MR, Van der Meer JWM, et al: Effect of monomeric immunoglobulin G (IgG) on the clearance of soluble aggregates of IgG in man. J Clin Lab Immunol 35: 9–15, 1991.

    PubMed  CAS  Google Scholar 

  188. Herberman RB: Natural killer cells. Annu Rev Med 37: 347–352, 1986.

    Article  PubMed  CAS  Google Scholar 

  189. Krahenbuhl O, Tschopp J: Perforin-induced pore formation. Immunol Today 12: 399–402, 1991.

    Article  PubMed  CAS  Google Scholar 

  190. Ritz J: The role of natural killer cells in immune surveillance. N Engl J Med 320: 1748–1749, 1989.

    Article  PubMed  CAS  Google Scholar 

  191. Biron CA, Byron KS, Sullivan JL: Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320: 1731–1735, 1989.

    Article  PubMed  CAS  Google Scholar 

  192. Lane HC, Fauci AS: Immunological abnormalities in the acquired immunodeficiency syndrome. Annu Rev Immunol 3: 477–500, 1985.

    Article  PubMed  CAS  Google Scholar 

  193. Van Voorhis WE, Valinsky J, Hoffman E, et al: The relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication. J Exp Med 158: 174–191, 1983.

    Article  PubMed  Google Scholar 

  194. Stingl G, Katz SI, Clement L, et al: Immunological functions of la-bearing epidermal Langerhans cells. J Immunol 121: 2005–2013, 1978.

    PubMed  CAS  Google Scholar 

  195. Ballieux RE, Heynen CJ: Functional T cell subsets defined by monoclonal antibodies. Immunol Rev 74: 5–28, 1983.

    Article  PubMed  CAS  Google Scholar 

  196. Meuer SC, Schlossmann SF, Reinherz EL: Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ recognize products of different major histocompatibility complex regions. Proc Natl Acad Sci USA 128: 463–468, 1982.

    Google Scholar 

  197. Thomas Y, Rogozinski L, Irigoyen OH, et al: Functional analysis of human T cell subsets defined by monoclonal antibodies. IV. Induction of suppressor cells within the OOKT4+ population. J Exp Med 154: 459–467, 1981.

    Article  PubMed  CAS  Google Scholar 

  198. Hahn H, Kaufmann SHE: The role of cell-mediated immunity in bacterial infections. Rev Infect Dis 3: 1221–1250, 1981.

    Article  PubMed  CAS  Google Scholar 

  199. Murray HW: How protozoa evade intracellular killing. Ann Intern Med 98: 1016–1018, 1983.

    PubMed  CAS  Google Scholar 

  200. Bermudez LE, Young LS: Tumor necrosis factor alone or in combination with IL-2, but not IFN-γ, is associated with macrophage killing of Mycobacterium avium complex. J Immunol 140: 3006–3013, 1988.

    PubMed  CAS  Google Scholar 

  201. Adams DO, Hamilton TA: The cell biology of macrophage activation. Annu Rev Immunol 2: 283–318, 1984.

    Article  PubMed  CAS  Google Scholar 

  202. Siegel RL, Issekutz T, Schwaber J: Deficiency of T helper cells in transient hypogammaglobulinemia of infancy. N Engl J Med 305: 1307–1313, 1981.

    Article  PubMed  CAS  Google Scholar 

  203. Hunninghake GW, Crystal RG: Pulmonary sarcoidosis: A disorder mediated by excess helper-T lymphocyte activity at sites of disease activity. N Engl J Med 305: 429–434, 1981.

    Article  PubMed  CAS  Google Scholar 

  204. Kallenberg CGM, Torensma R, The TH: The immune response to primary immunogens in man. In Reeves WG (ed): Recent Developments in Clinical Immunology. Elsevier, Amsterdam, 1984, pp. 1–26.

    Google Scholar 

  205. Weinberg ED: Pregnancy-associated depression of cell-mediated immunity. Rev Infect Dis 6: 814–831, 1984.

    Article  PubMed  CAS  Google Scholar 

  206. Styrt B, Sugarman B: Estrogens and infection. Rev Infect Dis 13: 1139–1150, 1991.

    Article  PubMed  CAS  Google Scholar 

  207. Skamene E (ed): Genetic Control of Host Response to Infection and Malignancy. Alan Liss, New York, 1985, 858 pp.

    Google Scholar 

  208. Van Eeden W, de Vries RRP, Van Rood JJ: The genetic approach to infectious disease, with special emphasis on the MHC. Disease Markers 1: 221–242, 1983.

    Google Scholar 

  209. de Vries RRP, Meera Khan P, Bernini LF, et al: Genetic control of survival in epidemics. J Immunogenet 6: 271–287, 1979.

    Article  PubMed  Google Scholar 

  210. Hill AVS, Allsop CEM, Kwiatowski D, et al: Common West African HLA antigens are associated with protection from severe malaria. Nature (London) 352: 595–600, 1991.

    Article  CAS  Google Scholar 

  211. de Vries RRP, Ottenhoff TH, Van Schooten WCA: HLA and mycobacterial disease. Springer Sem Immunopathol 10: 305–318, 1988.

    Article  Google Scholar 

  212. Pollack MS, Rich RR: The HLA complex and the pathogenesis of infectious diseases. J Infect Dis 151: 1–8, 1985.

    Article  PubMed  CAS  Google Scholar 

  213. Chandra RK: Nutrition, immunity and infection: Present knowledge and future directions. Lancet 1: 688–691, 1983.

    PubMed  CAS  Google Scholar 

  214. Keusch GT, Wilson CS, Waksal SD: Nutrition, host defenses and the lymphoid system. In Gallin JI, Fauci AS (eds): Advances in Host Defense Mechanisms, Vol 2. Raven Press, New York, 1983, pp. 275–359.

    Google Scholar 

  215. Salimonu LS, Ojo-Amaize E, Williams AIO, et al: Depressed natural killer cell activity in children with protein calorie malnutrition. Clin Immunol Immunopathol 24: 1–7, 1982.

    Article  PubMed  CAS  Google Scholar 

  216. Sommer A, Tarwotjo I, Djunaedi, et al: Impact of vitamin A supplementation on childhood mortality: A randomised controlled community trial. Lancet 1: 1169–1173, 1986.

    Article  PubMed  CAS  Google Scholar 

  217. Hussey GD, Klein M: A randomized controlled trial of vitamin A in children with severe measles. N Engl J Med 323: 160–164, 1990.

    Article  PubMed  CAS  Google Scholar 

  218. Rhamatullah L, Underwood BA, Thulasiraj RD, et al: Reduced mortality among children in southern India receiving a small weekly dose of vitamin A. N Engl J Med 323: 929–935, 1990.

    Article  Google Scholar 

  219. West CE, Rombout JHW, Van der Zijp AJ, et al: Vitamin A and immune function. Proc Nutr Soc 50: 251–262, 1991.

    Article  PubMed  CAS  Google Scholar 

  220. Sugarman B: Zinc and infection. Rev Infect Dis 5: 137–147, 1983.

    Article  PubMed  CAS  Google Scholar 

  221. Tucker SB, Schroeter AL, Brown PW Jr, et al: Acquired zinc deficiency: Cutaneous manifestations typical of acrodermatitis enteropathica. JAMA 235: 2399–2402, 1976.

    Article  PubMed  CAS  Google Scholar 

  222. Chandra RK, Au B, Woodford G, et al: Iron status, immunocom-petence and susceptibility to infection in iron metabolism. Ciba Found Symp, No. 51, Elsevier, Amsterdam, 1977, pp. 249–268.

    Google Scholar 

  223. Bullen JJ, Griffiths E (eds): Iron and Infection. John Wiley, Chichester, 1987.

    Google Scholar 

  224. Murray MJ, Murray AB, Murray MB, et al: The adverse effect of iron repletion on the course of certain infections. Br Med J 2: 113–115, 1978.

    Article  Google Scholar 

  225. van Asbeck BS, Verbrugh HA, van Oost BA, et al: Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload. Br Med J 284: 542–544, 1982.

    Article  Google Scholar 

  226. Boelaert JR, Van Landuyt HW, Valcke VJ, et al: The role of iron overload in Y. enterocolitica and Y. pseudotuberculosis bacteremia in hemodialysis patients. J Infect Dis 156: 384–387, 1987.

    Article  PubMed  CAS  Google Scholar 

  227. Craddock PR, Yawata Y, van Santen L: Acquired phagocyte dysfunction: A complication of the hypophosphatemia of parenteral hyperalimentation. N Engl J Med 290: 1403–1407, 1974.

    Article  PubMed  CAS  Google Scholar 

  228. Freeman J, Goldmann DA, Smith NE, et al: Association of intravenous lipid emulsion and coagulase negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med 323: 301–308, 1990.

    Article  PubMed  CAS  Google Scholar 

  229. Long JG, Keyserling HL: Catheter-related infection in infants due to an unusual lipophilic yeast — Malassezia furfur. Pediatrics 76: 896–900, 1985.

    PubMed  CAS  Google Scholar 

  230. Robin AP, Arain I, Phuangsab A, et al: Intravenous fat emulsion acutely suppresses neutrophil chemiluminescence. J Parent Ent Nutr 13: 608–613, 1989.

    Article  CAS  Google Scholar 

  231. Smith D, Peter G, Ingram DL, et al: Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae type B. Pediatrics 52: 637–640, 1973.

    PubMed  CAS  Google Scholar 

  232. Adamkin D, Stitzel A, Urmson J, et al: Activity of the alternative pathway of complement in the newborn infant. J Pediatr 93: 604–608, 1978.

    Article  PubMed  CAS  Google Scholar 

  233. Marodi L, Leijh PCJ, Braat A, et al: Opsonic activity of cord blood sera against various species of microorganisms. Pediatr Res 19: 433–436, 1985.

    Article  PubMed  CAS  Google Scholar 

  234. Park BH, Holmes B, Good RA: Metabolic activities in leucocytes of newborn infants. J Pediatr 76: 237–241, 1970.

    Article  PubMed  CAS  Google Scholar 

  235. McCracken GH, Eichenwald HF: Leucocyte function and the development of opsonic and complement activity in the neonate. Am J Dis Child 121: 120–126, 1971.

    PubMed  Google Scholar 

  236. Schuit KE, Powall DA: Phagocyte dysfunction in monocytes of normal newborn infants. Pediatrics 65: 501–504, 1980.

    PubMed  CAS  Google Scholar 

  237. Marodi L, Leijh PCJ, van Furth R: Characterization and functional capacities of human cord blood granulocytes and monocytes. Pediatr Res 18: 1127–1131, 1984.

    Article  PubMed  CAS  Google Scholar 

  238. Marodi L, Jzerniczky J, Csorba S, et al: Chemotactic and random movement of cord blood granulocytes. Experientia 40: 1407–1410, 1984.

    Article  PubMed  CAS  Google Scholar 

  239. Marodi L, Csorba S, Nagy B: Chemotactic and random movement of human newborn monocytes. Eur J Pediatr 135: 73–85, 1980.

    Article  PubMed  CAS  Google Scholar 

  240. van Tol MJD, Zijlstra J, Thomas CMG, et al: Distinct role of neonatal and adult monocytes in the regulation of the in vitro antigen-induced plaque-forming cell response in man. J Immunol 133: 1902–1908, 1984.

    PubMed  Google Scholar 

  241. Kohl S, Frazier JJ, Greenberg SB, et al: Interferon induction of natural killer cytotoxicity in human neonates. J Pediatr 98: 379–384, 1981.

    Article  PubMed  CAS  Google Scholar 

  242. Wakasugi N, Virelizier JL: Defective IFN-alpha production in the human neonate: Dysregulation rather than intrinsic abnormality. J Immunol 134: 167–171, 1985.

    PubMed  CAS  Google Scholar 

  243. Phair J, Kauffman CA, Bjornson A: Failure to respond to influenza vaccine in the aged: Correlation with B cell number or function. J Lab Clin Med 92: 822–828, 1978.

    PubMed  CAS  Google Scholar 

  244. Roberts-Thomson IC, Whittingham S, Youngchaiyud U, et al: Aging, immune response and mortality. Lancet 2: 368–370, 1974.

    Article  PubMed  CAS  Google Scholar 

  245. Wiedermann CJ, Niedermuhlbichler M, Beimpold H, et al: In vitro activation of neutrophils of the aged by recombinant growth hormone. J Infect Dis 164: 1017–1020, 1991.

    Article  PubMed  CAS  Google Scholar 

  246. Gardner ID: The effect of aging on susceptibility to infections. Rev Infect Dis 2: 801–810, 1980.

    Article  PubMed  CAS  Google Scholar 

  247. Saltzman RL, Peterson PK: Immunodeficiency of the elderly. Rev Infect Dis 9: 1127–1139, 1987.

    Article  PubMed  CAS  Google Scholar 

  248. Mackowiak PA: Direct effects on hyperthermia on pathogenic microorganisms: Teleologic implications with regard to fever. Rev Infect Dis 3: 508–520, 1981.

    Article  PubMed  CAS  Google Scholar 

  249. Jampel HD, Duff GW, Gershon RK, et al: Fever and immunoregulation. III. Hyperthermia augments the primary in vitro humoral response. J Exp Med 157: 1229–1238, 1983.

    Article  PubMed  CAS  Google Scholar 

  250. Hanson DF, Murphy PA, Silicano R, et al: The effect of temperature on the activation of thymocytes by interleukins I and II. J Immunol 130: 216–221, 1983.

    PubMed  CAS  Google Scholar 

  251. Dinarello CA, Dempsey RA, Allegretta M, et al: Inhibitory effects of elevated temperature on human cytokine production and natural killer activity. Cancer Res 46: 6236-6241.

    Google Scholar 

  252. Roberts NJ: Impact of temperature elevation on immunologic defenses. Rev Infect Dis 13: 462–472, 1991.

    Article  PubMed  Google Scholar 

  253. Shavit Y, Lewis JW, Terman GW, et al: Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 223: 188–190, 1984.

    Article  PubMed  CAS  Google Scholar 

  254. Young RA: Stress proteins in immunology. Annu Rev Immunol 8: 401–420, 1990.

    Article  PubMed  CAS  Google Scholar 

  255. Schwartz MN: Stress and the common cold. N Engl J Med 325: 654–656, 1991.

    Article  Google Scholar 

  256. Cohen S, Tyrell DAJ, Smith AP: Psychological stress and susceptibility to the common cold. N Engl J Med 325: 607–612, 1991.

    Google Scholar 

  257. Van der Meer JWM, Guiot HFL, van den Broek PJ, et al: Infections in bone marrow transplant recipients. Semin Hematol 21: 123–140, 1984.

    PubMed  Google Scholar 

  258. Witherspoon RP, Lum LG, Storb R: Immunological reconstitution after human marrow grafting. Semin Hematol 21: 2–10, 1984.

    PubMed  CAS  Google Scholar 

  259. Weeks JC, Tierney MR, Weinstein MC: Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia. N Engl J Med 325: 81–86, 1991.

    Article  PubMed  CAS  Google Scholar 

  260. Bennett C, Vardiman J, Golomb H: Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. Am J Med 80: 891–896, 1986.

    Article  PubMed  CAS  Google Scholar 

  261. Engleman EJ, Benike CJ, Hoppe RT, et al: Autologous mixed lymphocyte reaction in patients with Hodgkin’s disease. J Clin Invest 66: 149–158, 1980.

    Article  PubMed  CAS  Google Scholar 

  262. Ward PA, Berenberg JC: Defective regulation of inflammatory mediators in Hodgin’s disease. N Engl J Med 290: 76–80, 1974.

    Article  PubMed  CAS  Google Scholar 

  263. Weitzman SA, Aisenberg, AC, Siber GR, et al: Immunity in treated Hodgkin’s disease. N Engl J Med 297: 245–248, 1977.

    Article  PubMed  CAS  Google Scholar 

  264. Chilcote RR, Baehner RL, Hammond D: Septicemia and meningitis in children splenectomized for Hodgkin’s disease. N Engl J Med 295: 798–800, 1976.

    Article  PubMed  CAS  Google Scholar 

  265. Weitzman S, Aisenberg AC: Fulminant sepsis after the successful treatment of Hodgkin’s disease. Am J Med 62: 47–50, 1977.

    Article  PubMed  CAS  Google Scholar 

  266. Schwartz PE, Sterioff S, Mucha P, et al: Post splenectomy sepsis and mortality in adults. JAMA 284: 2279–2283, 1982.

    Article  Google Scholar 

  267. Kullberg BJ, Westendorp RGJ, Van’t Wout JW, et al: Purpura fulminans and symmetrical peripheral gangrene caused by Capnocytophaga canimorsus (formerly DF-2) septicemia — A complication of a dog bite. Medicine (Baltimore) 70: 287–292, 1991.

    Article  CAS  Google Scholar 

  268. Hosea SW, Brown EJ, Hamburger MI, et al: Opsonic requirements for intravascular clearance after splenectomy. N Engl J Med 304: 245–250, 1981.

    Article  PubMed  CAS  Google Scholar 

  269. Benner R, Hijmans W, Haayman JJ: The bone marrow: The major source of serum immunoglobulins but still a neglected site of antibody formation. Clin Exp Immunol 46: 1–8, 1981.

    PubMed  CAS  Google Scholar 

  270. Schumacker MJ: Serum immunoglobulin and transferrin levels after childhood splenectomy. Arch Dis Child 45: 114–117, 1970.

    Article  Google Scholar 

  271. Di Padova F, Durig M, Harder F, et al: Impaired antipneumococcal antibody production in patients without spleens. Br Med J 290: 14–16, 1985.

    Article  Google Scholar 

  272. Amlot PL, Hayes AE: Impaired human antibody response to the thymus independent antigen DNP-Ficoll after splenectomy. Lancet 1: 1000–1011, 1985.

    Google Scholar 

  273. Carlisle HN, Saslaw S: Properdin levels in splenectomized persons. Proc Soc Exp Biol Med 102: 150–155, 1959.

    PubMed  CAS  Google Scholar 

  274. Broome CV, Facklam RR, Fraser DW: Pneumococcal disease after pneumococcal vaccination: An alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med 303: 549–552, 1980.

    Article  PubMed  CAS  Google Scholar 

  275. Barret-Connor E: Infection and sickle cell anemia. In Allen JC (ed): Infection in the Compromised Host: Clinical Correlations and Therapeutic Approaches, 2nd ed. Williams &Wilkins, Baltimore, 1981, pp. 107–120.

    Google Scholar 

  276. Ballester OF, Prasad AS: Anergy, zinc deficiency and decreased nucleoside phosphorylase activity in patients with sickle cell anemia. Ann Intern Med 98: 180–182, 1983.

    PubMed  CAS  Google Scholar 

  277. Amman AJ, Addiego J, Wara DW, et al: Polyvalent pneumococcal-polysaccharide immunization of patients with sickle cell anemia and patients with splenectomy. N Engl J Med 297: 897–900, 1977.

    Article  Google Scholar 

  278. Allen JC: The diabetic as a compromised host. In Allen JC (ed): Infection and the Compromised Host: Clinical Correlations and Therapeutic Approaches, 2nd ed. Williams &Wilkins, Baltimore, 1981, pp. 229–270.

    Google Scholar 

  279. Meyers BR, Wormser G, Hirschman SZ, et al: Rhinocerebral mucormycosis: Premortem diagnosis and therapy. Arch Intern Med 139: 557–563, 1979.

    Article  PubMed  CAS  Google Scholar 

  280. Rubin J, Yu VL: Malignant external otitis: Insights into pathogenesls, clinical manifestations, diagnosis and therapy. Am J Med 85: 391–398, 1988.

    Article  PubMed  CAS  Google Scholar 

  281. Artis WM, Fountain JA, Delacher HK, et al: A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: Transferrin and iron availability. Diabetes 31: 1109–1114, 1982.

    Article  PubMed  CAS  Google Scholar 

  282. Brayton RG, Stokes PE, Schwartz MS, et al: Effect of alcohol and various diseases on leukocyte mobilization, phagocytosis and intracellular bacterial killing. N Engl J Med 282: 123–128, 1970.

    Article  PubMed  CAS  Google Scholar 

  283. Mowat AG, Baum J: Chemotaxis of polymorphonuclear leucocytes from patients with diabetes mellitus. N Engl J Med 284: 621–627, 1971.

    Article  PubMed  CAS  Google Scholar 

  284. Miller ME, Baker L: Leucocyte functions in juvenile diabetes mellitus: Humoral and cellular aspects. J Pediatr 81: 979–982, 1972.

    Article  PubMed  CAS  Google Scholar 

  285. Hill HR, Augustine NH, Rallison ML, et al: Defective monocyte chemotactic responses in diabetes mellitus. J Clin Immunol 3: 70–77, 1983.

    Article  PubMed  CAS  Google Scholar 

  286. Sheldon WH, Bauer H: The development of the acute inflammatory response to experimental cutaneous mucormycosis in normal and diabetic rabbits. J Exp Med 110: 845–859, 1959.

    Article  PubMed  CAS  Google Scholar 

  287. Bagdade JD, Root RK, Bulger RJ: Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 23: 9–15, 1974.

    PubMed  CAS  Google Scholar 

  288. Chernew I, Braude AI: Depression of phagocytosis by solutes in concentrations found in the kidney and urine. J Clin Invest 41: 1945–1951, 1962.

    Article  PubMed  CAS  Google Scholar 

  289. Nolan CM, Beaty HN, Bagdade JD: Further characterization of the impaired bactericidal function of granulocytes in patients with poorly controlled diabetes. Diabetes 27: 889–894, 1978.

    PubMed  CAS  Google Scholar 

  290. Tan JS, Anderson JL, Watanakunakom C, et al: Neutrophil dysfunction in diabetes mellitus. J Lab Clin Med 85: 26–33, 1975.

    PubMed  CAS  Google Scholar 

  291. Berken A, Shermann AA: Reticuloendothelial system phagocytosis in diabetes mellitus. Diabetes 23: 218–220, 1974.

    PubMed  CAS  Google Scholar 

  292. Maccuish AC, Urbaniak SJ, Campbell CJ, et al: Phytohemagglutinin transformation and circulating lymphocyte subpopulations in insulin-dependent diabetic patients. Diabetes 23: 708–712, 1974.

    PubMed  CAS  Google Scholar 

  293. Eliashiv A, Olumide F, Norton L, et al: Depression of cell-mediated immunity in diabetes. Arch Surg 113: 1180–1183, 1978.

    Article  PubMed  CAS  Google Scholar 

  294. Mahmoud AAF, Rodman HM, Mandel MA, et al: Induced and spontaneous diabetes mellitus and suppression of cell-mediated immunologic responses. J Clin Invest 57: 362–367, 1976.

    Article  PubMed  CAS  Google Scholar 

  295. Parry MF, Root RK, Metcalf JA, et al: Myeloperoxidase deficiency, prevalence and clinical significance. Ann Intern Med 95: 293–301, 1981.

    PubMed  CAS  Google Scholar 

  296. Cech P, Stalder H, Widmann JJ, et al: Leucocyte myeloperoxidase deficiency and diabetes mellitus associated with Candida albicans liver abscess. Am J Med 66: 149–153, 1979.

    Article  PubMed  CAS  Google Scholar 

  297. Montgomerie JZ, Kalmanson GM, Guze LB: Renal failure and infection. Medicine (Baltimore) 47: 1–32, 1968.

    CAS  Google Scholar 

  298. Clarke IA, Ormond DJ, Miller TE: Host immune status in uremia. V. Effect of uremia on resistance to bacterial infection. Kidney Int 24: 66–73, 1983.

    Article  PubMed  CAS  Google Scholar 

  299. Perescenschi G, Zakouth V, Spirer Z, et al: Leucocyte mobilization by epinephrine and hydrocortisone in patients with chronic renal failure. Experientia 33: 1529–1530, 1977.

    Article  PubMed  CAS  Google Scholar 

  300. Perillie PE, Nolan JP, Finch SC: Studies of the resistance to infection in diabetes mellitus: Local exudative cellular response. Lab Clin Med 59: 1008–1015, 1962.

    CAS  Google Scholar 

  301. Salant DF, Glover AM, Anderson R, et al: Depressed neutrophil chemotaxis in patients with chronic renal failure and after renal transplantation. J Lab Clin Med 88: 536–545, 1976.

    PubMed  CAS  Google Scholar 

  302. Abrutyn E, Solomons NW, St Clair L, et al: Granulocyte function in patients with chronic renal failure: Surface adherence, phagocytosis, and bactericidal activity in vitro. J Infect Dis 135: 1–8, 1977.

    Article  PubMed  CAS  Google Scholar 

  303. Urbantiz D, Sieberth HG: Impaired phagocytic activity of human monocytes in respect to reduced antibacterial resistance in uremia. Clin Nephrol 4: 13–17, 1975.

    Google Scholar 

  304. Nelson J, Ormrod DJ, Muller TE: Host immune status in uremia. IV. Phagocytosis and the inflammatory response in vivo. Kidney Int 23: 312–319, 1983.

    Article  PubMed  CAS  Google Scholar 

  305. Kirkpatrick CH, Wilson WEC, Talmage DW: Immunologic studies in human organ transplantation. I. Observation and characterization of suppressed cutaneous reactivity in uremia. J Exp Med 119: 727–742, 1964.

    Article  PubMed  CAS  Google Scholar 

  306. Newsberry WM, Sanford JP: Defective cellular immunity in renal failure: Depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum. J Clin Invest 50: 1262–1271, 1971.

    Article  Google Scholar 

  307. Daniels JC, Sakae H, Remmers Ar, et al: In vitro reactivity of human lymphocytes in chronic uraemia: Analysis and interpretation. Clin Exp Immunol 8: 213–227, 1971.

    PubMed  CAS  Google Scholar 

  308. Miller TE, Stewart E: Host immune status in uraemia. I. Cell-mediated immune mechanisms. Clin Exp Immunol 41: 115–122, 1980.

    PubMed  CAS  Google Scholar 

  309. Stevens CE, Alter HJ, Taylor PE, et al: Hepatitis B vaccine in patients receiving hemodialysis: Immunogencity and efficacy. N Engl J Med 311: 496–511, 1984.

    Article  PubMed  CAS  Google Scholar 

  310. Crosnier J, Jungers P, Courouce AM, et al: Randomized placebo-controlled trial of hepatitis B surface antigens vaccine in French haemodialysis units. Lancet 1: 797–800, 1981.

    Article  PubMed  CAS  Google Scholar 

  311. Desmyter J, Colaert J, de Groote G, et al: Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff: Double-blind placebo-controlled trial. Lancet 2: 1323–1328, 1983.

    Article  PubMed  CAS  Google Scholar 

  312. Lelie PN, Reesink HW, De Jong-van Manen ST, et al: Immune response to a heat-inactivated hepatitis B surface antigen from 3 to 27 g. Arch Intern Med 145: 305–309, 1985.

    Article  PubMed  CAS  Google Scholar 

  313. Meuer SC, Dumann H, Meyer zum Buschenfelde KH, et al: Low dose interleukin-2 induces systemic immune responses against HbsAg in immunodeficient non-responders to hepatitis B vaccination. Lancet 1: 15–18, 1989.

    Article  PubMed  CAS  Google Scholar 

  314. Ruddy MC, Rubin AL, Novogrodsky A, et al: Decreased macrophage-mediated suppression of lympocyte activation in chronic renal failure. Am J Med 75: 571–579, 1983.

    Article  PubMed  CAS  Google Scholar 

  315. Sengar DPS, Rashid A, Harris JE: In vitro reactivity of lymphocytes obtained from uraemic patients maintained by haemodialysis. Clin Exp Immunol 21: 298–305, 1975.

    PubMed  CAS  Google Scholar 

  316. Langhoff E, Ladefoged J: Cellular immunity in renal failure: Depression of lymphocyte transformation by uraemia and methylprednisolone. Int Arch Allergy Appl Immunol 74: 241–245, 1984.

    Article  PubMed  CAS  Google Scholar 

  317. Boelaert JR, Daneeis RF, Schurgers ML, et al: Iron overload in hemodialysis patients increases the risk of bacteraemia: A prospective study. Nephrol Dial Transplant 5: 1330–1334, 1990.

    Google Scholar 

  318. Boelaert JR, Vergauwe PL, Vandepitte JM: Mucormycosis infection in dialysis patients. Ann Intern Med 107: 782–783, 1987.

    PubMed  CAS  Google Scholar 

  319. Gloor HJ, Nichols WK, Sorkin MI, et al: Peritoneal access and related complications in continuous ambulatory peritoneal dialysis. Am J Med 74: 593–598, 1983.

    Article  PubMed  CAS  Google Scholar 

  320. Verbrugh HA, Keane WF, Hoidal JR, et al: Peritoneal macrophages and opsonins: Antibacterial defense in patients on chronic peritoneal dialysis. J Infect Dis 147: 1018–1029, 1983.

    Article  PubMed  CAS  Google Scholar 

  321. Keane WF, Peterson PK: Host defense mechanisms of the peritoneal cavity and continuous ambulatory peritoneal dialysis. Peritoneal Dialysis Bull 4: 122–127, 1984.

    Google Scholar 

  322. Amair P, Khanna R, Leibel B, et al: Continuous ambulatory peritoneal dialysis in diabetics with endstage renal disease. V Engl J Med 306: 625–630, 1982.

    Article  CAS  Google Scholar 

  323. Gluckman SJ, Dvorak VC, MacGregor RR: Host defenses during prolonged alcohol consumption in a controlled environment. Arch Intern Med 137: 1539–1543, 1977.

    Article  PubMed  CAS  Google Scholar 

  324. MacGregor RR, Spagnuolo PJ, Lentnek AE: Inhibition of granu-locyte adherence by ethanol, prednisone, and aspirin measured with an assay system. N Engl J Med 291: 642–646, 1974.

    Article  PubMed  CAS  Google Scholar 

  325. MacGregor RR: Alcohol and immune defense. JAMA 256: 1474–1479, 1986.

    Article  PubMed  CAS  Google Scholar 

  326. Bermudez L, Young LS: Ethanol augments intracellular survival of Mycobacterium avium complex and impairs macrophage response to cytokines. J Infect Dis 163: 1286–1292, 1991.

    Article  PubMed  CAS  Google Scholar 

  327. Berenyi MR, Straus B, Cruz D: In vitro and in vivo studies of cellular immunity in alcoholic cirrhosis. Am J Dig Dis 19: 199–205, 1974.

    Article  PubMed  CAS  Google Scholar 

  328. Saxena QB, Mezey E, Adler WH: Regulation of natural killer activity in vivo: The effect of alcohol on human peripheral blood natural killer activity. Int J Cancer 26: 413–417, 1980.

    Article  PubMed  CAS  Google Scholar 

  329. Wilcox CM, Dismukes WE: Spontaneous bacterial peritonitis: A review of pathogenesis, diagnosis and treatment. Medicine (Baltimore) 66: 447–456, 1987.

    CAS  Google Scholar 

  330. DeMeo AN, Andersen BR: Defective chemotaxis associated with a serum inhibitor in cirrhotic patients. N Engl J Med 286: 735–740, 1972.

    Article  PubMed  CAS  Google Scholar 

  331. Blussé van Oud Alblas A, Janssens AR, Leijh PCJ, et al: Functions of granulocytes and monocytes in primary biliary and alcoholic cirrhosis. Clin Exp Immunol 62: 724–731, 1985.

    Google Scholar 

  332. Wijke RJ, Rajkovic IA, Williams R: Impaired opsonization by serum from patients with chronic liver disease. Clin Exp Immunol 51: 91–98, 1983.

    Google Scholar 

  333. Runyon BA: Patients with deficient ascites fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 8: 632–635, 1988.

    Article  PubMed  CAS  Google Scholar 

  334. Sorrell MF, Leavy CM: Lymphocyte transformation and alcoholic liver injury. Gastroenterology 63: 1020–1028, 1972.

    PubMed  CAS  Google Scholar 

  335. Staples PJ, Gerding DN, Decker JL, et al: Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 17: 1–10, 1974.

    Article  PubMed  CAS  Google Scholar 

  336. Abeles M: The rheumatic patient as a compromised host. In Allen JC (ed): Infection and the Compromised Host: Clinical Correlations and Therapeutic Approaches, 2nd ed. Williams &Wilkins, Baltimore, 1981, pp. 197–227.

    Google Scholar 

  337. Ginzler E, Diamond H, Kaplan D, et al: Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 21: 37–47, 1978.

    Article  PubMed  CAS  Google Scholar 

  338. Moutsopoulos HM, Gallagher JD, Decker JL, et al: Herpes zoster in patients with systemic lupus erythematosus. Arthritis Rheum 21: 798–802, 1978.

    Article  PubMed  CAS  Google Scholar 

  339. Clark RA, Kimball HR, Decker JL: Neutrophil chemotaxis in systemic lupus erythematosus. Ann Rheum Dis 33: 167–172, 1984.

    Article  Google Scholar 

  340. Perez HD, Lipton M, Goldstein IM: A specific inhibitor of complement (C5) derived chemotactic activity in serum from patients with systemic lupus erythematosus. Clin Res 26: 519A, 1978.

    Google Scholar 

  341. Jasin HE, Orozco JH, Ziff M: Serum heat labile opsonins in systemic lupus erythematosus. J Clin Invest 53: 343–353, 1974.

    Article  PubMed  CAS  Google Scholar 

  342. Zurier RB: Reduction of phagocytosis and lysosomal enzyme release from human leucocytes by serum from patients with lupus erythematosus. Arthritis Rheum 19: 73–78, 1976.

    Article  PubMed  CAS  Google Scholar 

  343. Kimball HR, Wolff SM, Talal N, et al: Marrow granulocyte reserves in the rheumatic diseases. Arthritis Rheum 16: 345–352, 1973.

    Article  PubMed  CAS  Google Scholar 

  344. Rosenthal CJ, Franklin EC: Depression of cellular mediated immunity in systemic lupus erythematosus. Arthritis Rheum 18: 207–217, 1975.

    Article  PubMed  CAS  Google Scholar 

  345. Mowat AG, Baum J: Chemotaxis of polymorphonuclear leucocytes from patients with rheumatoid arthritis. J Clin Invest 59: 2541–2549, 1971.

    Article  Google Scholar 

  346. BarEli M, Ehrenfeld M, Litvin Y, et al: Monocyte function in rheumatoid arthritis. Scand J Rheumatol 9: 17–23, 1980.

    CAS  Google Scholar 

  347. Turner RA, Schumacher HR, Myers AR: Neutrophil chemotaxis in rheumatic diseases. J Clin Invest 52: 1632–1635, 1974.

    Article  Google Scholar 

  348. Breedveld FC, Fibbe WE, Hermans J, et al: Factors influencing the incidence of infections in Felty’s syndrome. Arch Intern Med 147: 915–920, 1987.

    Article  PubMed  CAS  Google Scholar 

  349. Mackowiak PA: Microbial synergism in human infections. N Engl J Med 298: 21–26, 83-87, 1978.

    Article  PubMed  CAS  Google Scholar 

  350. O’Grady F, Smith H (eds): Micmbial Pertubation of Host Defenses. Academic Press, London, New York, 1981, 254 pp.

    Google Scholar 

  351. Solberg CO, Helium KB: Neutrophil granulocyte function in bacterial infection. Lancet 2: 727–730, 1972.

    Article  PubMed  CAS  Google Scholar 

  352. Barbour AG, Allred CD, Solberg CO, et al: Chemiluminescence by polymorphonuclear leukocytes from patients with active bacterial infection. J Infect Dis 141: 14–20, 1980.

    Article  PubMed  CAS  Google Scholar 

  353. Parenti DM, Syndman DR: Capnocytophaga species: Infections in non-immunocompromised and immunocompromised hosts. J Infect Dis 151: 140–147, 1985.

    Article  PubMed  CAS  Google Scholar 

  354. Shurin SB, Socransky SS, Sweeney E, et al: A neutrophil disorder induced by Capnocytophaga, a dental microorganism. N Engl J Med 301: 849–854, 1979.

    Article  PubMed  CAS  Google Scholar 

  355. Rubin RH, Cosimi AB, Tolkoff-Rubin NE, et al: Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation 24: 458–464, 1977.

    Article  PubMed  CAS  Google Scholar 

  356. Chatterjee SN, Fiala M, Weiner J, et al: Primary cytomegalovirus infection and opportunistic infections: Incidence in renal transplant recipients. JAMA 240: 2446–2449, 1978.

    Article  PubMed  CAS  Google Scholar 

  357. Rand KH, Pollard RB, Merigan TC: Increased pulmonary super-infections in cardiac transplant patients undergoing primary cytomegalovirus infection. N Engl J Med 298: 951–953, 1978.

    Article  PubMed  CAS  Google Scholar 

  358. Carney WP, Rubin RH, Hoffman RA, et al: Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis. J Immunol 126: 2114, 1981.

    PubMed  CAS  Google Scholar 

  359. van Es A, van Gemert GW, Baldwin WK, et al: Viral infection and T-lymphocyte subpopulations in renal transplant recipients. N Engl J Med 309: 110–111, 1983.

    Google Scholar 

  360. La Quaglia MP, Tolkoff-Rubin NE, Dienstag J, et al: Impact of hepatitis on renal transplantation. Transplant 32: 504–507, 1981.

    Article  Google Scholar 

  361. Greene WC: Mechanisms of disease: The molecular biology of human immunodeficiency virus type 1 infection. N Engl J Med 324: 308–315, 1991.

    Article  PubMed  CAS  Google Scholar 

  362. Smith PD, Ohura K, Masur H, et al: Monocyte function in the acquired immunodeficiency syndrome. J Clin Invest 74: 2121–2128, 1984.

    Article  PubMed  CAS  Google Scholar 

  363. Berenguer J, Solera J, Diaz MD, et al: Listeriosis in patients infected with human immunodeficiency virus. Rev Infect Dis 13: 115–121, 1991.

    Article  PubMed  CAS  Google Scholar 

  364. Sobel JD: Controversial aspects of candidiasis in the acquired immunodeficiency syndrome. In Van den Bossche H, Mackenzie DWR, Cauwenbergh, G, et al. (eds): Mycoses in AIDS Patients. Plenum Press, New York, 1990, pp. 93–100.

    Chapter  Google Scholar 

  365. Lazzarin A, Uberti Foppa C, Galli M, et al: Impairment of polymorphonuclear function in patients with the acquired immunodeficiency syndrome and with lymphadenopathy syndrome. Clin Exp Immunol 65: 105–111, 1986.

    PubMed  CAS  Google Scholar 

  366. Ellis M, Gupta S, Galant S, et al: Impaired neutrophil function in patients with AIDS or AIDS related complex: A comprehensive evaluation. J Infect Dis 158: 1268–1276, 1988.

    Article  PubMed  CAS  Google Scholar 

  367. Redd SC, Rutherford GW, Sande MA, et al: The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis 162: 1012–1017, 1990.

    Article  PubMed  CAS  Google Scholar 

  368. Schlamm HT, Yancovitz SR: Haemophilus influenzae pneumonia in young adults with AIDS, ARC, or risk of AIDS. Am J Med 86: 11–14, 1989.

    Article  PubMed  CAS  Google Scholar 

  369. Steinhoff MC, Auerbach BS, Nelson KE, et al: Antibody responses to Haemophilus influenzae type B vaccines in men with the human immunodeficiency virus infection. N Engl J Med 325: 1837–1842, 1991.

    Article  PubMed  CAS  Google Scholar 

  370. Jacobson MA, Gellermann H, Chambers H: Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex. Am J Med 65: 172–176, 1988.

    Article  Google Scholar 

  371. Stevens DA, Denning DW: Pulmonary aspergillosis in AIDS. N Engl J Med 325: 356–357, 1991.

    Google Scholar 

  372. Schaffner A: Pulmonary aspergillosis in AIDS. N Engl J Med 325: 355–356, 1991.

    Article  Google Scholar 

  373. Denning DW, Follansbee SE, Scolaro M, et al: Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 325: 654–662, 1991.

    Article  Google Scholar 

  374. Graham BS, Tucker WS: Opportunistic infections in endogenous Cushing syndrome. Ann Intern Med 101: 334–338, 1984.

    PubMed  CAS  Google Scholar 

  375. Fauci AS, Dale DC, Balow JE: Glucocorticosteroid therapy: Mechanisms of action and clinical considerations. Ann Intern Med 84: 304–315, 1976.

    PubMed  CAS  Google Scholar 

  376. Stuck AE, Minder CE, Frey FJ: Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 11: 954-963.

    Google Scholar 

  377. Schneiderman CA, Wilson JW: Effects of corticosteroids on complement and the neutrophilic polymorphonuclear leucocyte. Transplant Proc 7: 41–48, 1979.

    Google Scholar 

  378. Butler WT, Rossen RD: Effects of corticosteroids on immunity in man. J Clin Invest 52: 2629–2640, 1973.

    Article  PubMed  CAS  Google Scholar 

  379. Suda T, Miura Y, Ijima H: The effect of hydrocortisone on human granulopoiesis in vitro. Exp Hematol 11: 114–121, 1983.

    PubMed  CAS  Google Scholar 

  380. Dale DC, Fauci AS, Guerry D, et al: Comparison of agents producing a neutrophilic leukocytosis in man: Hydrocortisone, prednisone, endotoxin, and etiocholanolone. J Clin Invest 56: 808–813, 1975.

    Article  PubMed  CAS  Google Scholar 

  381. Dale DC, Fauci AS, Wolff SM: Alternate-day prednisone: Leukocyte kinetics and susceptibility to infections. N Engl J Med 291: 1154–1158, 1974.

    Article  PubMed  CAS  Google Scholar 

  382. Wiener SL, Wiener R, Urivetzky M, et al: The mechanism of action of a single dose of methylprednisolone on acute inflammation in vivo. J Clin Invest 56: 679–689, 1975.

    Article  PubMed  CAS  Google Scholar 

  383. Thompson J, van Furth R: The effect of glucocorticosteroids on the kinetics of mononuclear phagocytes. J Exp Med 131: 429–442, 1970.

    Article  PubMed  CAS  Google Scholar 

  384. Rinehart JJ, Balcerzak SP, Sagone AL: Effects of corticosteroid on monocyte function. J Clin Invest 53: 1327–1343, 1974.

    Google Scholar 

  385. Rinehart JJ, Sagone AL, Balcerzak SP, et al: Effects of corticosteroid therapy on human monocyte function. N Engl J Med 292: 236–241, 1975.

    Article  PubMed  CAS  Google Scholar 

  386. van Zwet TL, Thompson J, van Furth R: Effect of glucocorticosteroids on the phagocytosis and intracellular killing by peritoneal macrophages. Infect Immun 12: 699–705, 1975.

    PubMed  CAS  Google Scholar 

  387. Atkinson JP, Frank MM: Cortisone inhibition of complement independent erythrocyte clearance. Blood 44: 629–637, 1974.

    PubMed  CAS  Google Scholar 

  388. Werb ZA: Hormone receptors and hormonal regulation of macrophage physiological functions. In van Furth R (ed): Mononuclear Phagocytes: Functional Aspects. Martinus Nijhoff, The Hague, Boston, London, 1980, pp. 809–829.

    Google Scholar 

  389. Knudsen PJ, Dinarello CA, Strom TB: Glucocorticosteroids inhibit transcriptional and posttranscriptional expression of inter-leukin-1 in U937 cells. J Immunol 139: 4129–4135, 1987.

    PubMed  CAS  Google Scholar 

  390. Leudke CE, Cerami A: Interferon-gamma overcomes glucocorticoid suppression of cachectin/tumor necrosis factor biosynthesis by murine macrophages. J Clin Invest 86: 1234–1240, 1990.

    Article  Google Scholar 

  391. Dannenberg AM Jr: The anti-inflammatory effects of glucocorticosteroids: A brief review of the literature. Inflammation 3: 329–343, 1979.

    Article  PubMed  CAS  Google Scholar 

  392. Cupps TR, Fauci AS: Corticosteroid-mediated immunoregulation in man. Immunol Rev 65: 134–155, 1982.

    Article  Google Scholar 

  393. Gustafson TL, Schaffner W, Lavely GB, et al: Invasive aspergillosis in renal transplant recipients: Correlation with corticosteroid therapy. J Infect Dis 148: 230–238, 1983.

    Article  PubMed  CAS  Google Scholar 

  394. Gershwin ME, Goetzl EJ, Steinberg AD: Cyclophosphamide: Use in practice. Ann Intern Med 80: 531–540, 1974.

    PubMed  CAS  Google Scholar 

  395. Balow JE: Cyclosphosphamide suppression of established cell-mediated immunity. J Clin Invest 56: 65–70, 1975.

    Article  PubMed  CAS  Google Scholar 

  396. Fauci AS, Wolff SM, Johnson JS: Effects of cyclophosphamide upon the immune response in Wegener’s granulomatosis. N Engl J Med 285: 1493–1496, 1971.

    Article  PubMed  CAS  Google Scholar 

  397. Ten Berge RJM, Schellekens PTA: A critical analysis of the use of azathioprine in clinical medicine. Neth J Med 26: 164–171, 1983.

    PubMed  CAS  Google Scholar 

  398. Losito A, Williams DG, Cooke G, et al: The effects on polymorphonuclear leukocyte function of prednisolone and azathioprine in vivo and prednisolone, azathioprine, and 6-mercaptopurine in vivo. Clin Exp Immunol 32: 423–428, 1978.

    PubMed  CAS  Google Scholar 

  399. Hersh ER, Wong VG, Freireich EJ: Inhibition of local inflammatory response in man by antimetabolites. Blood 27: 38–48, 1966.

    PubMed  CAS  Google Scholar 

  400. Cseuz R, Panayi GS: The inhibition of NK cell function by azathioprine during the treatment of patients with rheumatoid arthritis. Br J Rheumatol 29: 358–362, 1990.

    Article  PubMed  CAS  Google Scholar 

  401. Forre O, Bjerkhoel F, Salvesen CF, et al: An open controlled randomized comparison of cyclosporin and azathioprine in the treatment of rheumatoid arthritis. Arthritis Rheum 30: 88–92, 1987.

    Article  PubMed  CAS  Google Scholar 

  402. Anderson PA, West SG, O’Dell JR, et al: Weekly pulse methotrexate in rheumatoid arthritis: Clinical and immunological effect in a randomized double blind study. Ann Intern Med 103: 489–496, 1985.

    Google Scholar 

  403. Boerbooms AMT, Jeurissen MEC, Van de Putte LBA: Methotrexate in refractory rheumatoid arthritis. Clin Rheumatol 7: 249–256, 1988.

    Article  PubMed  CAS  Google Scholar 

  404. Hyams JS, Donaldson MH, Metcalf JA, et al: Inhibition of human granulocyte function by methotrexate. Cancer Res 38: 640–655, 1978.

    Google Scholar 

  405. Johnston CA, Russel AS, Kovithavongs T, et al: Measures of immunologic and inflammatory responses in vitro in rheumatic arthritis treated with methotrexate. J Rheumatol 13: 294–296, 1986.

    PubMed  CAS  Google Scholar 

  406. Johnson WJ, Dimartine MJ, Meunier PC, et al: Methotrexate inhibits macrophage activations as well as vascular and cellular inflammatory events in rat adjuvant induced arthritis. J Rheumatol 15: 745–749, 1988.

    PubMed  CAS  Google Scholar 

  407. Kim JH, Perfect JR: Infection and cyclosporine. Rev Infect Dis 11: 677–690, 1989.

    Article  PubMed  CAS  Google Scholar 

  408. Granelli-Piperno A, Inaba K, Steinman RM: Stimulation of lymphokine release from T lymphoblasts, requirements for mRNA synthesis and inhibition by cyclosporin A. J Exp Med 160: 1792–1802, 1984.

    Article  PubMed  CAS  Google Scholar 

  409. Hauser WE, Remington JS: The effect of antibiotics on the humoral and cell-mediated immune responses. In Sabath LD (ed): Action of Antibiotics in Patients. H Huber, Berne, 1982, pp. 127–147.

    Google Scholar 

  410. Cosimi AB: Clinical usefulness of antilymphocyte antibodies. Transplant Proc 15: 583–589, 1983.

    Google Scholar 

  411. Thistlethwaite Jr JR, Stuart JK, Mayes JT, et al: Complications and monitoring of OKT3 therapy. Am J Kidney Dis 11: 112–119, 1988.

    PubMed  Google Scholar 

  412. Frenken LAM, Hoitsma AJ, Tax WJM, et al: Prophylactic use of anti CD3 monoclonal antibody WT32 in kidney transplantation. Transplant Proc 23: 1072–1073, 1991.

    PubMed  CAS  Google Scholar 

  413. Rubin RH, Cosimi AB, Hirsch MD, et al: Effects of antithymocyte globulin on cytomegalovirus infection in renal transplant recipients. Transplantation 31: 143–145, 1981.

    Article  PubMed  CAS  Google Scholar 

  414. Macris MP, Van Buren CT, Sweeney MS, et al: Selective use of OKT3 in heart transplantation with the use of risk factor analysis. J Heart Transplant 8: 296–302, 1989.

    PubMed  CAS  Google Scholar 

  415. Gordon RD, Tzakis AG, Iwatsuki S, et al: Experience with Orthoclone OKT3 monoclonal antibody in liver transplantation. Am J Kidney Dis 11: 141–144, 1988.

    PubMed  CAS  Google Scholar 

  416. Renlund DG, O’Connell JB, Gilbert EM, et al: A prospective comparison of murine monoclonal CD-3 (OKT3) antibodybased and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Transplantation 47: 599–605, 1989.

    Article  PubMed  CAS  Google Scholar 

  417. Millis JM, McDiarmid SV, Hiatt JR, et al: Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation. Transplantation 47: 82–88, 1989.

    Article  PubMed  CAS  Google Scholar 

  418. Grino JM, Alsino J, Sabater R, et al: Antilymphoblast globulin, cyclosporine and steroids in cadaveric renal transplantation. Transplantation 49: 1114–1117, 1990.

    Article  PubMed  CAS  Google Scholar 

  419. Van Rood JJ, Claas FHJ: The influence of allogeneic cells on the human T and B cell repertoire. Science 248: 1388–1393, 1990.

    Article  PubMed  Google Scholar 

  420. Lederman MM, Ratnoff OD, Scillian JJ, et al: Impaired cell-mediated immunity in patients with classic hemophilia. N Engl J Med 308: 79–82, 1983.

    Article  PubMed  CAS  Google Scholar 

  421. Gascon P, Zoumbos NC, Young NS, et al: Immunological abnormalities in patients receiving multiple blood transfusions. Ann Intern Med 100: 173–177, 1984.

    PubMed  CAS  Google Scholar 

  422. Wing EJ, Bruns FJ, Fraley DS, et al: Infectious complications with plasmapheresis in rapidly progressive glomerulonephritis. JAMA 244: 2423–2426, 1980.

    Article  PubMed  CAS  Google Scholar 

  423. Pohl MA, Lan SP, Berl T, et al: Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. Ann Intern Med 114: 924–929, 1991.

    PubMed  CAS  Google Scholar 

  424. Doria G, Agarossi G, Adorini L: Selective effects of ionizing radiations on the immunoregulatory cells. Immunol Rev 65: 23–54, 1982.

    Article  PubMed  CAS  Google Scholar 

  425. Baehner RL, Neiburger RG, Johnson ED, et al: Transient bactericidal defect of peripheral blood phagocytes from children with acute lymphoblastic leukemia receiving craniospinal irradiation. N Engl J Med 289: 1209–1213, 1973.

    Article  PubMed  CAS  Google Scholar 

  426. Slater JM, Ngo E, Lau BHS: Effect of therapeutic irradiation on the immune responses. Am J Roentgenol 126: 313–320, 1976.

    CAS  Google Scholar 

  427. Strober S, Dhillon M, Schubert, et al: Acquired immune tolerance to cadaveric renal allografts: A study of three patients treated with total nodal irradiation. N Engl J Med 321: 28–33, 1989.

    Article  PubMed  CAS  Google Scholar 

  428. Eskola J, Kayhty H, Takala AK, et al: A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type B disease. N Engl J Med 323: 1381–1387, 1990.

    Article  PubMed  CAS  Google Scholar 

  429. Schaad UB, Lang AB, Wedgwood J, et al: Safety and immunogenicity of Pseudomonas conjugate: A vaccine in cystic fibrosis. Lancet 338: 1236–1237, 1991.

    Article  PubMed  CAS  Google Scholar 

  430. Gallico GG III, O’Connor NE, Compton CC, et al: Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 311: 448–451, 1984.

    Article  PubMed  Google Scholar 

  431. Brown Gl, Nanney LB, Griffen J, et al: Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med 321: 76–80, 1989.

    Article  PubMed  CAS  Google Scholar 

  432. Perrillo RP, Schiff ER, Davis GL, et al: A randomized controlled trial of interferon alpha-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 323: 295–301, 1990.

    Article  PubMed  CAS  Google Scholar 

  433. Davis GL, Balart LA, Schiff ER, et al: Treatment of chromc hepatitis C with recombinant interferon alpha: A multicenter randomized, controlled trial. N Engl J Med 321: 1501–1506, 1989.

    Article  PubMed  CAS  Google Scholar 

  434. Reichman RC, Oakes D, Bonnes W, et al: Treatment of Condylomata acuminatum with three different interferon-gamma preparations administered parenterally: A double-blind, placebocontrolled trial. J Infect Dis 162: 1270–1276, 1990.

    Article  PubMed  CAS  Google Scholar 

  435. Nathan CF, Kaplan G, Levis WR, et al: Local and systemic effects of intradermal recombinant interferon gamma in patients with lepromatous leprosy. N Engl J Med 315: 6–15, 1986.

    Article  PubMed  CAS  Google Scholar 

  436. Badaro R, Falcoff E, Badaro FS, et al: Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. N Engl J Med 322: 16–20, 1990.

    Article  PubMed  CAS  Google Scholar 

  437. International Chronic Granulomatous Disease Cooperative Study Group: Controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 324: 509–516, 1991.

    Article  Google Scholar 

  438. Bernhisel-Broadbent J, Camargo EE, Jaffe HS, et al: Recombinant human interferon-γ as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease. J Infect Dis 163: 908–911, 1991.

    Article  PubMed  CAS  Google Scholar 

  439. Vogels MTE, Van der Meer JWM: The use of immunomodulators in the non-specific therapy of bacterial infections. Antimicrob Agents Chemother 36: 1–5, 1992.

    PubMed  CAS  Google Scholar 

  440. Doi S, Saiki O, Hara T, et al: Administration of recombinant IL-2 augments the level of serum IgM in an IL-2 deficient patient. Dur J Pediatr 148: 630–633, 1989.

    CAS  Google Scholar 

  441. Pahwa R, Chatila T, Paradise C, et al: Recombinant interleukin-2 therapy in severe combined immunodeficiency. Proc Natl Acad Sci USA 86: 5069–5073, 1989.

    Article  PubMed  CAS  Google Scholar 

  442. Cohn ZA, Kaplan G: Hansen’s disease, cell-mediated immunity and recombinant lymphokines. J Infect Dis 163: 1195–1200, 1991.

    Article  PubMed  CAS  Google Scholar 

  443. Klempner MS, Noring R, Mier JW, et al: An acquired chemotactic defeat in neutrophils from patients receiving interleukin-2 immunotherapy. N Engl J Med 322: 959–965, 1990.

    Article  PubMed  CAS  Google Scholar 

  444. Buckley RH, Schiff RI: Drug therapy: The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med 325: 110-117.

    Google Scholar 

  445. Van der Meer JWM, De Windt GE, Van den Broek PJ, et al: Subcutaneous immunoglobulin substitution in hypogam-maglobulinemia. In Krijnen HW, Strengers PFW, Van Aken WG (eds): Immunoglobulins. CLB, Amsterdam, 1988, pp. 71–76.

    Google Scholar 

  446. Gardulf A, Hammarstrom L, Smith CIE: Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion. Lancet 338: 162–166, 1991.

    Article  PubMed  CAS  Google Scholar 

  447. Winston DJ, Young LS: Immunization of the compromised host against infectious complications. In Allen JC (ed): Infection and the Compromised Host: Clinical Correlations and Therapeutic Approaches. Williams &Wilkins, Baltimore, 1981, pp. 37–89.

    Google Scholar 

  448. Winston DJ, Ho WG, Lin CH, et al: Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med 106: 12–18, 1987.

    PubMed  CAS  Google Scholar 

  449. Reed EC, Bowden RA, Dandliker PS, et al: Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med 109: 733–788, 1988.

    Google Scholar 

  450. Emanuel D, Cunningham I, Jules-Elysee K, et al: Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and highdose intravenous immune globulin. Ann Intern Med 109: 777–782, 1988.

    PubMed  CAS  Google Scholar 

  451. Sullivan KM, Kipecky KJ, Jocom J, et al: Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 323: 705–712, 1990.

    Article  PubMed  CAS  Google Scholar 

  452. Keusch GT, Ambinder EP, Kovacs I, et al: Role of opsonins in clinical response to granulocyte transfusion in granulocytopenic patients. Am J Med 73: 552–563, 1982.

    Article  PubMed  CAS  Google Scholar 

  453. Ziegler EJ, Fisher CJ, Sprung CL, et al: Treatment of gramnegative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin: A randomized, double-blind, placebo-controlled trial. N Engl J Med 324: 429–436, 1991.

    Article  PubMed  CAS  Google Scholar 

  454. Greenberg RN, Wilson KM, Kunz AY, et al: Randomized double blind phase II study of anti-endotoxin antibody (E5) as adjuvant therapy in humans with serious gram-negative infections. Prog Clin Biol Res 367: 179–186, 1991.

    PubMed  CAS  Google Scholar 

  455. Tracey KJ, Fong Y, Hesse DG, et al: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (London) 330: 662–664, 1988.

    Article  Google Scholar 

  456. Scharfman WB, Tillotson JR, Taft EG, et al: Plasmapheresis for meningococcemia with disseminated intravascular coagulation. N EnglJ Med 300: 1277–1278, 1979.

    CAS  Google Scholar 

  457. Bjorvatn B, Bjeretnals L, Fadnes HO, et al: Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange. Br Med J 288: 439–441, 1984.

    Article  CAS  Google Scholar 

  458. Van Deuren M, Santman FW, van Dalen R, et al: Plasma exchange or whole blood exchange in fulminant meningococcal sepsis. Clin Infect Dis 19: 424–430, 1992.

    Article  Google Scholar 

  459. Winston DJ, Ho WG, Gale RP: Therapeutic granulocyte transfusions in documented infections: A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med 97: 509–515, 1982.

    PubMed  CAS  Google Scholar 

  460. Van der Meer JWM, van den Broek PJ: Present status of the management of patients with defective phagocytic function. Rev Infect Dis 6: 107–121, 1984.

    Article  PubMed  Google Scholar 

  461. Buescher ES, Gallin JI: Leukocyte transfusions in chronic granulomatous disease. N Engl J Med 307: 800–803, 1982.

    Article  PubMed  CAS  Google Scholar 

  462. Hassner A, Adelman DC: Biological response modifiers in primary immunodeficiency disorders. Ann Intern Med 115: 292–307, 1991.

    Google Scholar 

  463. Hershfield MS, Buckley RH, Greenberg ML, et al: Treatment of adenosine deaminase deficiency with polyethyleneglycol-modified adenosine deaminase. N Engl J Med 316: 589–596, 1987.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of General Internal Medicine, University Hospital St. Radboud, 6500 HB, Nijmegen, The Netherlands

    Jos W. M. van der Meer

Authors
  1. Jos W. M. van der Meer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Massachusetts General Hospital, Boston, Massachusetts, USA

    Robert H. Rubin M.D. (Chief of Transplantation Infectious Disease, Director of the Center for Experimental Pharmacology and Therapeutics) (Chief of Transplantation Infectious Disease, Director of the Center for Experimental Pharmacology and Therapeutics)

  2. Division of Health Sciences and Technology, Harvard University-Massachusetts Institute of Technology, Cambridge, Massachusetts, USA

    Robert H. Rubin M.D. (Chief of Transplantation Infectious Disease, Director of the Center for Experimental Pharmacology and Therapeutics) (Chief of Transplantation Infectious Disease, Director of the Center for Experimental Pharmacology and Therapeutics)

  3. Pacific California Medical Center, San Francisco, California, USA

    Lowell S. Young M.D. (Director of Kuzell Institute for Arthritis and Infectious Diseases, Chief of Division of Infectious Diseases) (Director of Kuzell Institute for Arthritis and Infectious Diseases, Chief of Division of Infectious Diseases)

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Plenum Publishing Corporation

About this chapter

Cite this chapter

van der Meer, J.W.M. (1994). Defects in Host Defense Mechanisms. In: Rubin, R.H., Young, L.S. (eds) Clinical Approach to Infection in the Compromised Host. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2490-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2490-8_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-44617-7

  • Online ISBN: 978-1-4615-2490-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation